Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Insect Protein on Performance and Hypertrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03034239
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : May 9, 2017
Sponsor:
Information provided by (Responsible Party):
University of Aarhus

Brief Summary:

Purpose: to study the effect of insect protein on performance and hypertrophy during 8 weeks of resistance training.

Hypothesis: Insect protein supplementation enhances the effect of resistance training on muscle mass and muscle strength.

Primary outcome: Muscle hypertrophy and muscle strength

Design: Two groups of healthy young men (age: 18-30 years) with resistance training experience, but no structural resistance training performed for the last 12 months. Randomized controlled intervention study +/- insect protein (placebo group ingest isocaloric carbohydrate). Both groups perform 8 weeks of progressive resistance training (4/week) aiming to induce muscle hypertrophy.


Condition or disease Intervention/treatment Phase
Protein Supplementation Dietary Supplement: Protein supplementation Other: Resistance training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: The Effect of Insect Protein on Performance and Hypertrophy During Eight Weeks of Resistance Training
Actual Study Start Date : March 20, 2017
Actual Primary Completion Date : May 1, 2017
Actual Study Completion Date : May 1, 2017

Arm Intervention/treatment
Experimental: Insect protein group
Exercise + insect protein 8 weeks of 4/week progressive resistance training (2 days upper body, 2 days lower body). Insect protein supplementation (4g/kg) after each training + before sleep at training days, and once in the morning at non training days.
Dietary Supplement: Protein supplementation
+ insect protein

Other: Resistance training
Resistance exercise

Placebo Comparator: Placebo group
Exercise + isocaloric carbohydrate 8 weeks of 4/week progressive resistance training (2 days upper body, 2 days lower body). Carbohydrate supplementation (isocaloric to protein group) after each training + before sleep at training days, and once in the morning at non training days.
Other: Resistance training
Resistance exercise




Primary Outcome Measures :
  1. Muscle hypertrophy [ Time Frame: 8 weeks ]
    muscle mass measured by DXA-scan


Secondary Outcome Measures :
  1. Muscle Strength [ Time Frame: 8 weeks ]
    muscle strength measured by maximal isometric muscle strength, 1RM at bench press and leg press and 80% 1RM to fatigue in bech and leg press



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy young men (age: 18-30 years) with experience in resistance training
  • 2 hours of physical exercise per week or more

Exclusion Criteria:

  • No structural resistance training for the last 12 months
  • No injuries
  • No smoking
  • No ingesting of protein or creating supplementations
  • No use of medicine which may influence the adaptation to strength training

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03034239


Locations
Layout table for location information
Denmark
Aarhus University, Department for Public Health, Section for Sport Science
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Layout table for investigator information
Principal Investigator: Mette Hansen, PhD University of Aarhus

Layout table for additonal information
Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT03034239     History of Changes
Other Study ID Numbers: Insect2017
First Posted: January 27, 2017    Key Record Dates
Last Update Posted: May 9, 2017
Last Verified: January 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertrophy
Pathological Conditions, Anatomical